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In addition to their potential for cell-based therapies in the treatment of disease and injury, the broad developmental capacity of human
embryonic stem cells (hESCs) offers potential for studying the origins of all human cell types. To date, the emergence of specialized cells from
hESCs has commonly been studied in tissue culture or in teratomas, yet these methods have stopped short of demonstrating the ESC potential
exhibited in the mouse (mESCs), which can give rise to every cell type when combined with blastocysts. Due to obvious barriers precluding the
use of human embryos in similar cell mixing experiments with hESCs, human/non-human chimeras may need to be generated for this purpose.
Our results show that hESCs can engraft into mouse blastocysts, where they proliferate and differentiate in vitro and persist in mouse/human
embryonic chimeras that implant and develop in the uterus of pseudopregnant foster mice. Embryonic chimeras generated in this way offer the
opportunity to study the behavior of specialized human cell types in a non-human animal model. Our data demonstrate the feasibility of this
approach, using mouse embryos as a surrogate for hESC differentiation.
© 2006 Published by Elsevier Inc.Keywords: Chimera; Mouse blastocyst; hESC; Human embryonic stem cells; DerivationIntroduction
Embryonic stem cells (ESCs) are a population of self-
renewing, pluripotent cells that are derived from the inner cell
mass (ICM) of mammalian blastocyst stage embryos and are
able to differentiate into all the cell types of the adult
(Rossant, 2001). In recent years, human embryonic stem cells
(hESCs) have generated tremendous enthusiasm for the
promise they provide to both revolutionize cell-based
therapies and regenerative medicine, as well as provide a
vehicle for the study of early human embryology. While
clinical application of hESCs does not necessarily depend on
their ability to mimic natural development, the capacity for
hESCs to model human embryogenesis, either as a whole or
in part, depends largely on the ability of these cells to
faithfully parallel their cognate population in a developing
human embryo.⁎ Corresponding author. Fax: +1 212 327 8685.
E-mail address: brvnlou@rockefeller.edu (A.H. Brivanlou).
1 Both authors contributed equally to the work.
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doi:10.1016/j.ydbio.2006.03.026To date, hESC differentiation has mostly been assayed by
two means: formation of embryoid bodies (EBs) and
teratomas, both of which contain representative cell types
from all three primary germ layers (Conley et al., 2004). Yet,
while the timing of gene expression in differentiating mouse
EBs can mirror embryonic gene expression (Keller et al.,
1993; Leahy et al., 1999), neither mESCs nor hESCs have
been shown to undergo axial morphogenesis within EBs. And
though hESCs can give rise to relatively organized tissue
rudiments within teratomas (Przyborski, 2005), they differen-
tiate in response to an environment that does not reflect the
developmental context of embryogenesis. For these reasons,
engraftment of hESCs into an embryonic environment may be
better suited to the study of specialized human cell types in a
live animal model.
Numerous studies have demonstrated the viability and
developmental potency of human stem cells within interspecies
chimeras: human mesenchymal stem cells injected into e11.5 rat
embryos have been shown to give rise to complex functional
structures of the kidney (Yokoo and Kawamura, 2005); hESCs
injected into an organogenesis stage chick embryo have been
shown to proliferate and contribute to neural cell types
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injected directly into the lateral ventricle of e14 fetal mouse
brains, they were shown to give rise to functional human
neurons within the adult mouse brain (Muotri et al., 2005). In
the present study, we use the mouse blastocyst as a host for
engraftment of hESCs. The advantages of using the blastocyst
stage mouse embryo as a host for engraftment of hESCs are
twofold: first, like the ICM and mESCs, hESCs are theoretically
capable of differentiating to any cell type; second, engraftment
into mouse embryos at the blastocyst stage allows for
integration at a point that is relatively close in developmental
timing.
As these types of experiments are currently prohibited by
the material transfer agreements attached to the NIH-registry
cell lines, none of these hESC lines could have been used. We
therefore isolated a new hESC line from human blastocysts
donated from IVF clinics, named “RUES1.” RUES1 had a
stable karyotype, expressed markers of pluripotency and
differentiated to derivatives of all three primary germ layers in
embryoid bodies as well as teratomas. Using both unmodified
and genetically marked RUES1, we show first that RUES1
injected into mouse blastocysts proliferated, intermingled and
differentiated along with host cells in cultured blastocyst
outgrowths. Strikingly, hESCs that engrafted to mouse
embryos localized to their niche of origin, the ICM, despite
a hundred million years of evolutionary distance. When
chimeric blastocysts were implanted transiently into pseudo-
pregnant foster mice, most of the resultant embryos were
developmentally abnormal, though RUES1 derivatives per-
sisted in rare embryos that proceeded through gastrulation and
displayed normal morphology at e8. This study establishes
the feasibility of adapting classic embryonic stem cell mixing
experiments for use with hESCs. These approaches can be
extended to take advantage of the large collection of mutant
mice for use as host, and genetically modified and/or diseased
hESCs as graft, to address both basic embryological
properties of hESCs as well as shed light on their potential
application for cell-based therapies.
Materials and methods
RUES1 derivation and culture
Derivation, culture and embryoid body formation were performed as
previously described (Thomson et al., 1998). Blastocysts frozen at day 6 post-
fertilization were donated with informed consent from embryos in excess of
clinical need according to institutional guidelines. Identifying information was
removed before receipt of the vials, and blastocysts were thawed by stepwise
removal of cryoprotectant. Blastocysts were washed two times in recovery
medium and incubated for 2 h before immunosurgery to allow for blastocoel
expansion and morphological grading. Recovery medium consisted of 10%
Plasmanate, 1× non-essential amino acids, 1× essential amino acids and 1×
GlutaMAX in M16 medium (Specialty Media). The blastocysts were treated
with 2 mg/ml pronase to remove the zona pellucida and then incubated in a 1:10
dilution of anti-human placental alkaline phosphatase antibody (DAKO). The
embryos were washed three times in recovery medium and incubated in a 1:10
dilution of guinea pig complement (Sigma) and monitored for trophectoderm
lysis. Lysed trophectoderm was removed by pipetting through a pulled Pasteur
pipette, and isolated ICMs were washed 2× in HUESM medium. HUESM
consisted of DMEM supplemented with 20% KSR, 1× non-essential aminoacids, 1× essential amino acids, 1× GlutaMAX and 20 ng/ml bFGF (Invitrogen).
Human LIF was added (12 ng/ml) during the initial outgrowth but was excluded
from subsequent culture. ICMs were plated on an MEF feeder layer, and
outgrowths were micro-dissected and transferred to fresh feeder layers for three
passages for expansion. Stable culture of RUES1 was maintained as previously
described (Sato et al., 2004; Xu et al., 2001). Embryoid bodies were generated
by incubation of cultures in dispase until colonies detatched from the substrate.
This was followed by culture of the aggregates in DMEM supplemented with
20% FCS, 1× penicillin–streptomycin, 1× GlutaMAX (all from Gibco) on non-
tissue-culture-treated Petri dishes coated with a thin layer of agarose to prevent
attachment.
Teratoma formation
To generate teratomas, 1–2 × 106 hESCs were injected into the rear leg
muscle of SCID/beige mice. Teratomas were allowed to develop for 6 weeks
and were then excised and fixed in neutral-buffered formalin and analyzed
histologically by trained pathologist. Some teratomas were fixed, equilibrat-
ed in 30% sucrose and embedded for cryosectioning. Sections were
processed immunohistochemically for markers of germ layers as described
above.
Immunofluorescence
Undifferentiated hESCs plated on thermanox™ coverslips coated with
MEFs or Matrigel, hESC-derived EBs, teratomas and chimeric embryos were
analyzed by immunofluorescence staining for markers of pluripotency and/or
differentiation. Briefly, samples were fixed in 4% paraformaldehyde, washed in
PBST and blocked in 5% donkey or goat serum. Samples were exposed to
primary antibodies in blocking solution overnight at 4°C, washed 3 times in
PBST and exposed to fluorescent-conjugated secondary antibodies. Primary
antibodies included Oct-3/4 (Signal Transduction labs), SSEA4, Tra-1-60, and
nestin (Chemicon), β-tubulinIII/Tuj1 (Sigma), Alpha-1-Fetoprotein (DAKO)
HNF3β, Sox2, Oct-3/4 (Santa Cruz), Muscle MHC/MF20 (Developmental
Studies Hybridoma Bank), Neurofilament Heavy Chain, Phospho-HistoneH3,
Desmin (Abcam), and Cdx2 (BioGenex). Alexa-conjugated secondary anti-
bodies, SytoxGreen and SytoxOrange nuclear counterstains were purchased
from Molecular Probes. Endogenous alkaline phosphatase was assayed using
manufacturer's instructions (Vector Labs). All imaging was performed using a
Zeiss Pascal confocal microscope.
Lentiviral vectors and infections
Supernatants containing infectious particles were collected 36 h after
calcium phosphate co-transfection of HEK 293 (Graham and van der Eb,
1973; Graham et al., 1977) cells with pTrip (Sirven et al., 2000, 2001),
psPAX2 (D. Trono Swiss Institute of Technology Lausanne), and pL-VSV-
G (Bartz and Vodicka, 1997; Yee et al., 1994). hESCs were infected at
5 × 105 ifu/ml.
Blastocyst injections and embryonic outgrowth culture
RUES1 hESCs were manually dissected into 10–15 cells clumps using
finely drawn glass Pasteur pipettes and injected into embryonic day 3.5
mouse blastocysts flushed from the uterine horns of Swiss Webster mice.
hESC clumps were drawn into custom pulled transfer pipettes with a 25 μm
bore (Eppendorf™) and injected into the blastocoel cavity of mouse embryos.
hESC-injected blastocysts were either fixed 24 h post-injection or cultured on
Matrigel™-coated tissue culture plastic in culture medium containing 15%
fetal bovine serum for 6 days. Resultant embryonic outgrowths were fixed
and processed immunocytochemically as described above.
RUES1 aggregation with mouse blastomere embryos
Embryonic day 2.5 mouse embryos were flushed from the oviduct of
superovulated CBA/B6 mice and treated with acid tyrodes to remove their
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was placed with a dispase-dissociated hESC clump of ∼10–15 cells, and
the plate was centrifuged briefly in order to combine them (adapted from
Nagy, 2003). Embryos were allowed to recover for 48 h, when they were
fixed and processed immunocytochemically as described above. Under
these conditions, mESCs aggregated in parallel showed contribution to host
ICM after 48 h.
Chimeric blastocyst implantation
Embryonic day 3.5 mouse blastocysts that were injected with hESCs
and allowed to recover for 6 h post-injection were transferred to the
uterine horns of pseudopregnant foster mice as previously described. Five
days following transfer, implanted embryos were recovered from the uterus
of foster mothers and examined for hESC contribution.Fig. 1. Derivation and pluripotent marker expression of RUES1 hESCs. RUES1 w
immunosurgery is shown (B). This ICM attached to the MEF feeder layer and produce
ratio (C). Colonies on MEFs (D, E, F, and I) and on Matrigel (G and H) were analyze
and TRA-1-60 (F) by immunofluorescence. Colonies on MEFs were also positive
pluripotency markers (J). Shown are amplification plots of relative fluorescence
amplification control. The no-RT controls are indicated for each primer. Red line
expression. Scale bars are: 20 μm in panel A; and 50 μm in panels D–I.Results
Derivation and characterization of RUES1
We isolated an hESC line on mouse embryonic fibroblasts
by immunosurgery from thawed blastocysts that had been
frozen at day six of in vitro development after in vitro
fertilization (Cowan et al., 2004; Thomson et al., 1998, Figs.
1A and B). Upon plating of the ICMs isolated from
blastocysts, one expanded with continued culture and gave
rise to colonies with tightly packed cells with a high nuclear
to cytoplasmic ratio (Fig. 1C). These could be maintained on
MEFs (Fig. 1E) by manual dissection (Mitalipova et al.,as derived from a frozen 6-day-old blastocyst (A). The ICM after isolation by
d a primary outgrowth of small ICM-like cells with a high nuclear to cytoplasmic
d for the presence of pluripotency markers Oct-3/4 (D and G), SSEA4 (E and H),
for alkaline phosphatase (I) by cytochemistry. Real-time RT-PCR analysis of
vs. cycle number for Oct-3/4, Nanog, and Cripto-1. β-2-microglobulin as an
s indicate the threshold cycle of amplification used to determine the level of
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Matrigel-coated plates in MEF conditioned medium (Xu et
al., 2001) (Fig. 1F) for more than 38 passages. This line was
named RUES1 (for Rockefeller University Embryonic Stem-
cell line 1). Karyotype analysis revealed that the line was
male [46, XY], and most cells had a normal karyotype (26/
30) after 6 passages (Supplemental Fig. 1). Time-lapse video-
microscopy established that the RUES1 cell cycle is about
24 h (data not shown). This is equivalent to the rate of most
hESCs, reported to be about 24 to 36 h, with a range of 12 h
to 72 h (Cowan et al., 2004).
RUES1 expressed previously described molecular markers
of pluripotency (Thomson et al., 1998; Brivanlou et al., 2003).
The markers Oct-3/4 (POU5F1, Figs. 1D and G), SSEA4 (Figs.
1E and H), TRA-1-60 (Fig. 1F), and alkaline phosphatase (Fig.
1I) were readily detected. By real-time RT-PCR, expression of
Oct-3/4, Nanog, and Cripto-1 (Fig. 1J) was also detected. We
have recently reported the identification of a set of genes that are
consistently enriched in undifferentiated hESCs across several
independent microarray studies (Suárez-Fariñas et al., 2005).
We verified the enrichment of 91 of these markers in RUES1
hESCs by real-time RT-PCR (Supplementary Table 1).
Together, these data demonstrate that RUES1 is similar to
previously reported cell lines in origin, growth properties, and
marker expression.
Differentiation of RUES1 into derivatives of all three
embryonic germ layers
RUES1 also formed complex and cystic embryoid bodies
when aggregated and cultured in suspension in vitro (Figs. 2A
and B). Embryoid bodies could be maintained in suspension
culture for at least 5 months. After prolonged in vitro culture or
after reattachment to adhesive substrates, embryoid bodies
generated multiple cell types indicative of the three embryonic
germ layers (Figs. 2C–F). Neural cell types were evident in
outgrowths from the EBs (data not shown). Immunostaining
for nestin and Neurofilament Heavy Chain (NFH) confirmed
the presence of ectoderm derivatives (Fig. 2C) in these
cultures. During culture, beating cardiac myocytes were
observed, indicating the presence of functional mesoderm
differentiation (arrow in Fig. 2B). Staining for Desmin
confirmed the presence of mesoderm (Fig. 2D); staining for
HNF3β demonstrated the presence of endoderm derivatives
(Fig. 2E). We also found an early marker of trophectoderm,
Cdx2 (Strumpf et al., 2005), in EB cultures (Fig. 2F). These
data indicated that RUES1 could be induced to form
derivatives of all three primary germ layers in vitro.
To further demonstrate the differentiation potential of
RUES1, we generated teratomas in SCID/beige mice and
analyzed for tissue derivatives of the three embryonic germ
layers (Figs. 2G–M and Supplementary Fig. 2). Several
teratomas were analyzed including a single teratoma from
which we could identify representatives of ectoderm, meso-
derm, and endoderm by histology (Figs. 2K–M and Supple-
mentary Figs. 2E–G). We immunostained a separate teratoma
for germ layer markers to verify these results and identifiedneuroepithelium that stained positively for nestin (Fig. 2G),
Tuj1, and NFH (Supplementary Figs. 2A and B); mesodermal
tissue stained positively for Desmin (Fig. 2H) and Muscle MHC
(Supplementary Fig. 2C); and endoderm tissue stained
positively for HNF3β (Fig. 2I) and AFP (Supplementary Fig.
2D). We also identified trophectoderm, as marked by Cdx2 (Fig.
2J). Taken together, the results presented above establish that
RUES1 is a bona fide new hESC line meeting the current
criteria of prolonged undifferentiated proliferation while
maintaining the ability to differentiate into trophectoderm and
germ layer derivatives.
hESCs incorporate and differentiate in mouse blastocyst
outgrowths
Although the functional qualities of mESCs and hESCs are
very much the same, mouse and human ESCs show significant
differences. For example, cell cycle length and the signaling
factors that mediate self-renewal have been shown to be
different between the two cell types (James et al., 2005; Sato et
al., 2004; Xu et al., 2002a,b). The fact that hESCs are grown on
top of MEFs in culture experiments clearly demonstrates that
embryonic cell types from the two species can coexist. But
factors secreted by MEFs are important for the maintenance of
self-renewal in hESCs, so it is possible that paracrine signaling
between mouse cells and hESCs within mosaic embryos could
affect the differentiation process of one or both cell types. In
order to assess the ability of hESCs to proliferate, integrate, and
differentiate in mouse embryos, we injected e3.5 blastocysts
with 10–15 cell clumps of RUES1 and cultured the embryos in
vitro for 6 days (Fig. 3). These experiments described below
were designed to minimize hESC input into host embryos, in
accordance with policies in place at the Rockefeller University,
and are also in line with guidelines recommended by the
National Academy of Sciences (http://www.books.nap.edu/
catalog/11278.html). Figs. 3A and B show the injection
protocol.
As RUES1 hESCs do not tolerate trypsin-passaging, two
independent means of RUES1 dissociation, trypsin and micro-
dissection into cell clumps, were compared for their ability to
integrate into host blastocysts. In each case, a total of 10 to 15
cells, either as individual cells or in clumps, were microinjected
into the blastocoel cavity of a mouse blastocyst. When trypsin-
dissociated cells were compared to cell clumps, micro-dissected
colonies showed the best quality and quantity of contribution
(data not shown). Other available cell lines have shown poor
recovery from trypsin-passaging in tissue culture (Amit et al.,
2000), and this enzymatic treatment may account for poor
contribution of trypsin-dissociated RUES1 hESCs to mouse
blastocysts. But another cell line HUES#6 (Cowan et al., 2004;
generously provided by Doug Melton), which is routinely
trypsin-passaged in cell culture, also showed poor contribution
(data not shown). For this reason, the embryonic chimeras in
these experiments were generated by injection of manually
dissociated clumps.
In order to determine whether human cells would proliferate
and mix with the mouse host, injected blastocysts were cultured
Fig. 2. Germ layer differentiation of RUES1 in embryoid bodies and teratomas. RUES1 generated complex aggregates after 14 days of in vitro differentiation in
suspension (A). These subsequently formed complex embryoid bodies during 2 months of culture (B). The arrow in panel B indicates an area of contracting cardiac
muscle after 2 months of culture, indicating mesoderm differentiation. When plated on adhesive substrates, the EBs generated multiple differentiated cell types,
including neural tissue (C). The neural cell types can be propagated in vitro and stain for molecular markers of ectoderm: nestin (C, blue) and Neurofilament Heavy
Chain (C, red). Mesoderm, marked by Desmin (D, red), and endoderm, marked by HNF3β (E, red), as well as trophectoderm, marked by Cdx2 (F, red), can also be
found in EBs. RUES1 at passage 11 was also injected intramuscularly into SCID/beige mice and allowed to develop for 6 weeks to generate teratomas. Germ layer
markers were verified by immunofluorescence and histology on cryosections of the teratoma (G–M). Examples of ectoderm: nestin (G, red) and retinal pigmented
epithelium (K), mesoderm: Desmin (H, red) and cartilage (L), and endoderm: HNF3β (I, red) and glandular tissue (M) are shown. In addition, trophectoderm: Cdx2 (J,
red) is present. SytoxGreen nuclear counterstain is shown in green. Scale bars are: 50 μm in panels A–J; 30 μm in panels K and M; and 60 μm in panel L.
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derivatives persisted in 14% of cultured chimeric blastocysts,
and resultant embryonic outgrowths showed a complex and
disorganized three-dimensional structure with human cells
present in significant numbers (>500 nuclei in some cases).
Human nuclei were predominantly concentrated in the
suspended body of the outgrowth, while the “stalk” by which
the outgrowth adhered to the extracellular matrix (star in Fig.
3F) was devoid of hESC derivatives. Cells were actively
proliferating, as evidenced by the co-localization of Phospho-
HistoneH3 (Gurley et al., 1978; green in Fig. 3G) and human
nuclear antigen (red in Fig. 3G). Relative to host cells, however,
human nuclei were underrepresented in all chimeric outgrowths
(Fig. 3F and data not shown). This evidence established thathESCs could proliferate and intermingle with their mouse
embryonic counterparts in cultured blastocyst outgrowths.
Mouse embryonic fibroblasts have commonly been used to
maintain the undifferentiated state of hESCs, so it is possible
that the mouse embryonic environment may impede the
differentiation of hESCs. In order to address this, we examined
whether human cells within the outgrowths expressed markers
of the differentiated state. Human cells derived from all three
germ layers were detected (Figs. 4E–J). Furthermore, we
concluded that all the human cells were differentiated as no
RUES1 nuclei were positive for the pluripotency marker Oct-3/
4. In fact, a cluster of Oct-3/4-positive mouse cells that was
retained in one outgrowth provided a valuable internal control
for the absence of Oct-3/4 in human cells (Figs. 4A–D).
Fig. 3. hESCs survive, proliferate, and incorporate into cultured mosaic embryos. RUES1 was dissociated enzymatically by trypsin or manually by micro-dissection
and injected into the blastocoel of e3.5 mouse embryos. The injection scheme is shown in panels A and B. hESC-injected embryos were cultured in vitro on Matrigel-
coated tissue culture plastic (C) for 6 days. Resultant outgrowths showed complex three-dimensional structure, and human cells were present in significant numbers
(D–I). Panel G shows human cells near the end of mitosis; Phospho-HistoneH3, which is a marker of mitosis, is shown in green. The inset in panel F is magnified as a
single optical section in panels H and I, which show intermingling of human cells with the host. Human nuclei are represented in red in panels E–I. SytoxGreen nuclear
counterstain is shown in blue. Scale bars—C, D, F, H, I—50 μm; G—20 μm.
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In order to localize RUES1 derivatives within chimeric
blastocysts and cultured outgrowths, we performed immuno-
cytochemistry on our samples using an antibody specific for
human nuclear antigen. While these methods were adequate for
our purposes, secondary detection by immunofluorescence can
result in signal artifacts that arise from non-specific binding of
primary or secondary antibodies. To avoid this possibility in our
subsequent experiments, we set out to generate hESCs thatstably express green fluorescent protein (GFP). Because
methods commonly used to generate stably expressing
mESCs by lipofection were not as effective in hESCs (data
not shown), we used lentiviral transduction to stably integrate
GFP into RUES1 (Fig. 5). We first transfected HEK 293 cells
with a lentiviral vector containing eGFP and used the
supernatant from these cells to infect RUES1 at 5 × 105
infectious units/ml. After manually selecting for regions of
strong GFP expression through two passages, homogenous,
GFP-expressing RUES1 colonies were obtained (Figs. 5B and
Fig. 4. hESCs differentiate into three primary germ layer derivatives within
mosaic outgrowths. RUES1 cells were injected into e3.5 mouse blastocysts and
cultured for 6 days on Matrigel. Resulting outgrowths were fixed and processed
immunohistochemically using antibodies specific for Oct-3/4 (green in panels B
and D), Neurofilament Heavy Chain (green in panel F), Desmin (green in panel
H), and HNF3β (green in panel J). Human nuclei are stained by an antibody to
human nuclear antigen in red and SytoxGreen nuclear counterstain in blue.
Panels C and D represent a magnified view of the inset in B. Scale bars—A–D, I
and J—50 μm; E–H—10 μm).
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than 10 passages.
hESCs can maintain their pluripotency within the mouse ICM
niche
Because in vitro culture of blastocyst outgrowths cannot
begin to recapitulate the dynamic process of early embryonic
development in vivo, it is unclear from these experiments
whether hESCs and mouse ICM derivatives would combine to
form a coherent embryo. It is possible that human cells are
growing ectopically in the host embryo and only become
intermingled with mouse cells by virtue of their proximity. This
possibility prompted us to ask whether RUES1 would integrate
into and maintain the identity of the host ICM shortly after
injection. In order to address this, we repeated the injection
protocol and examined the expression of Oct-3/4 after 24 h of
culture. Fig. 6 shows that RUES1 cells that incorporated
generated a small niche of Oct-3/4-positive cells among their
Oct-3/4 mouse counterparts in the ICM (Figs. 6A–H). In
contrast, we consistently observed that hESCs that did not
incorporate into the ICM were Oct-3/4-negative and showed
unhealthy nuclear morphology (arrow in Fig. 6C). In these
settings, we never found contribution of human cells to the
trophectoderm. Human cells that integrated into host ICM
maintained Oct-3/4 levels and were negative for the trophecto-
derm marker Cdx2 (Figs. 6F–H). From this evidence, we
concluded that the differentiated cells seen in the mosaic
outgrowths originated from the hESCs that engrafted into the
host ICM.
hESCs aggregated with blastomere stage mouse embryos
engraft into ICM
A common alternative to blastocyst injection for the
generation of embryonic chimeras entails the aggregation of
ESCs with pre-compacted blastomere stage embryos (Zeil-
maker, 1973; Nagy et al., 1993). Given the technical
difficulty and physical stress involved in the injection of
hESC clumps into mouse blastocysts, adapting aggregation
protocols to suit hESCs would not only allow for an increase
in the scale of chimera generation, but would also ensure
reduced trauma to engrafted hESCs. Furthermore, prior to
compaction, mammalian embryos have yet to make the cell
fate distinction between ICM, which gives rise to the embryo
proper, and trophectoderm, which mediates invasion of
uterine epithelium during implantation and gives rise to
extraembryonic tissues. While mESCs do not normally
differentiate to trophectoderm lineages in vitro, hESCs have
demonstrated this potential (Xu et al., 2002b). Hence,
engraftment of hESCs into mouse blastomere stage embryos
provides a means of testing the ability of hESCs to take on
dual cell fates (trophectoderm vs. ICM) concomitantly with
the cells of the host. To address these questions, we
combined dispase-dissociated RUES1 clumps with pre-
compaction embryos in conical bottomed wells followed by
mild centrifugation (Schematic shown in Fig. 6I). After 48 h,
Fig. 5. eGFP transduction of RUES1 by lentivirus. (A) Schematic map of the pTrip-eGFP vector (Sirven et al., 2000, 2001). Panels B and C show RUES1 cells viewed
with DIC (B), and composite of DIC and fluorescence in RUES1 transduced (at 5 × 105 ifu/ml) with pTrip-eGFP vector, after two rounds of manual passaging.
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in three independent experiments. Engrafted cells were
localized to the ICM of a vast majority (97%) of embryonic
chimeras that formed, and they retained the Oct-3/4-positive
identity of adjacent mouse cells (Figs. 6J–N). As was the
case for RUES1 hESCs injected into mouse blastocysts,
human cells did not exhibit the trophectoderm marker Cdx2
in successfully aggregated embryos (Figs. 6L–N). However,
in one individual case, aggregation resulted in a chimeric
blastocyst in which hESCs were not localized to the host
ICM (arrow in Fig. 6J). In this embryo, some human cells
retained Oct-3/4 expression, but surprisingly, a minority
exhibited Cdx2 expression (arrowhead in Fig. 6O), though at
a reduced level relative to host trophectoderm (Figs. 6O–Q);
and upon further differentiation in outgrowths after 6 days,
Cdx2-positive human cells were also evident (data not
shown). From these observations, we concluded that hESCs
localized to host ICM in embryonic chimeras whether they
were generated by blastocyst injection or morula aggregation.
hESCs persist in implanted embryonic chimeras in vivo
Given the strikingly disparate developmental schedules
for mouse and human embryogenesis, it is unexpected that
embryonic cell types from the two species could be
combined within chimeras to form a coherent embryo. To
determine whether embryonic chimeras generated by
blastocyst injection would give rise to developmentally
viable embryos in vivo, we transiently implanted hESC-
injected blastocysts into the uterus of pseudopregnant foster
mice and harvested them, along with uninjected controls, at
embryonic day 8 (Fig. 7). Of 28 chimeric embryos that
were implanted, 24 formed deciduae that contained
embryos. Thirteen of these embryos were phenotypically
normal and did not contain any GFP-positive RUES1
derivatives (Fig. 7A, left); 7 of the embryos were
developmentally delayed and did not contain RUES1derivatives (Fig. 7A, right); and 3 embryos contained
GFP-positive RUES1 derivatives but showed aberrant
morphology (Figs. 7B and C). Strikingly, one embryo of
the 28 was morphologically similar to normal littermates
but contained 10 GFP-positive hESC derivatives localized
to the prospective foregut endoderm and neuroepithelium
(Figs. 7D–H). The persistence of human cells in implanted
chimeras was supported by a separate data set, in which
human cells were shown by immunocytochemistry to persist
in rare embryos, specifically in the anterior neural folds of
embryonic chimeras at e8.5 (Figs. 7I–K). From these
experiments, we conclude that hESCs can engraft in
embryonic chimeras implanted in vivo and furthermore
that they can be maintained in an embryo that proceeds
normally through gastrulation.
Discussion
Embryonic cell mixing and recombination experiments
between related species are a traditional approach of
experimental embryology, used for more than a hundred
years to understand embryonic processes at the cellular level.
The origin of these methods can be traced to experiments in
which early embryonic explants were transplanted between
frog and newt gastrulae—an approach that allowed the
identification of the origins of inductive signals during
embryogenesis (Spemann, 1918, 1921; Spemann and Man-
gold, 1923). In the past few decades, pioneering experiments
have contributed greatly to the understanding of vertebrate
embryogenesis, but relative to other model species, a similar
understanding of our own development has been elusive.
hESCs have the potential to resolve this. In this study, we
chose to test the capacity of a new hESC line, RUES1, to
incorporate into the closely related embryonic environment of
the mouse ICM. We showed that hESCs engrafted into pre-
implantation stage mouse embryos and proliferated into
differentiated human derivatives in the context of host tissue
Fig. 6. RUES1 integrate into host ICM and retain pluripotent identity. Embryonic chimeras were generated by blastocyst injection (A–H) or aggregation (I–P) and
fixed 24 h or 48 h post-injection/aggregation, respectively, for immunohistochemical analysis. (A–D) Human cells detected by anti-human nuclear antibody (red in
panels B–D) that integrated into the host ICM showed healthy nuclear morphology (blue in panels B and D) and maintained Oct-3/4 (green in panels C and D). Human
cells that did not incorporate into host ICM exhibited unhealthy, apoptotic morphology and did not retain Oct-3/4 (arrowhead in panel C). (E–H) GFP expressing
hESCs (green in panels G and H) were negative for the trophectoderm marker Cdx2 (blue in panels F and H) in embryonic chimeras generated by blastocyst injection.
A schematic diagram showing methods used to generate chimeric embryos by aggregation of blastomere stage embryos with hESCs is shown in panel I. (J–N) A
majority of embryonic chimeras generated from morula aggregation showed localization of hESCs (green in panels K, M, and N) to host ICMwith retention of Oct-3/4
(red in K–N) and absence of Cdx2 (blue in panels K, L, and N). (O–Q) One embryo contained hESC derivatives (green in panels P and Q) that were positive for Cdx2
(arrowhead in panel O). Nuclear counterstain is shown in blue in panels B and D. Panels L–N and O–Q show magnified views of embryonic chimeras indicated by the
arrowhead and arrow, respectively, in panel J. Scale bars—50 μm.
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compatibility between both human and mouse cells in the
ICM of mouse blastocysts as well as following implantation
into pseudopregnant foster mice. These data establish for thefirst time that hESCs can integrate into the mouse embryo,
validating the potential for non-human embryos to serve as a
surrogate environment in which to study hESCs and their
derivatives.
Fig. 7. hESC derivatives are retained in embryonic chimeras following implantation in vivo. RUES1-injected blastocysts were implanted into the uterus of
pseudopregnant foster mice and recovered after 5 days of development. (A) Examples of implanted blastocysts that resulted in wild type phenotype (left) and aberrant/
delayed phenotype without GFP-positive hESC contribution (right). (B and C) Bright field and fluorescent images of abnormal embryos containing GFP-positive
hESC contribution. (D–H) Morphologically normal embryo containing 10 GFP-positive hESC derivatives. (D) Sagittal view; panel E shows a color-coded fate map
specifying prospective foregut region in yellow and prospective neuroepithelium in blue (Nagy, 2003). (F–H) Anterior view. (I–K) A section of the neural fold region
of an embryonic chimera at e8.5 was labeled by immunocytochemistry with the anti-human nuclear antigen antibody. Many RUES1 cells that were positive for the
anti-human nuclear stain are shown in red in panels I and K; pan-nuclear counterstain is shown in red in panels F and H and in blue in panels J and K; GFP-positive
cells are shown in green in panels C, G, and H. Scale bars—100 μm.
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that ESCs have the capacity to integrate into extra-species
hosts—mESCs differentiated in vitro to motor neurons
innervate chick hind legs (Wichterle et al., 2002); and
hESCs differentiate into neuronal cell types in ovo in the
context of the chick embryo (Goldstein et al., 2002) or when
injected directly into lateral ventricles of e14 fetal mouse
brains (Muotri et al., 2005). While these studies recombine
late stage or stage-mismatched tissue, our embryonic
chimeras are recombined from cells of the same stage as
the one from which they were derived: the blastocyst. Twenty
four hours after injection into mouse blastocysts, hESCs that
were not incorporated into the ICM showed fragmented
nuclear morphology suggestive of apoptosis or necrosis. And
those hESCs that did incorporate into ICM maintained Oct-3/
4 expression at levels similar to adjacent mouse cells, while
those that did not incorporate were negative for Oct-3/4.
Embryonic chimeras were also generated by aggregation of
hESCs with blastomere stage embryos, and 48 h after
aggregation, hESCs were again localized to the host ICM and
maintained Oct-3/4 levels similar to adjacent host cells.Localization of hESCs to host ICM is relevant to the ability
of embryonic chimeras to implant and develop in vivo.
Chimeras generated from aggregation of rat and mouse embryos
show varied developmental progress depending on the methods
used to combine them. When rat and mouse embryos are
combined at the blastomere stage, rat cells contribute to the
trophectoderm of the chimeras and they fail to implant into
mouse uterus, presumably due to an immune response against
the foreign rat component (Rossant, 1976). However, when
isolated rat ICM is injected into mouse blastocyst, rat cells do
not contribute to trophectoderm, and these chimeras are able to
implant (Gardner and Johnson, 1973, 1975). Our observation
that injected or aggregated hESCs engraft into host ICM and do
not contribute to host trophectoderm suggests that chimeras
generated by either method should at least be able to implant
into the uterus of mouse foster mothers. Indeed, embryonic
chimeras generated by blastocyst injection were able to implant
and develop within foster mice, though the influence of hESCs
seemed to disrupt embryogenesis in most cases.
The generation of interspecific chimeras using mouse pre-
implantation embryos was first accomplished in 1973, when
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embryos (Mulnard, 1973; Stern, 1973; Zeilmaker, 1973).
Since then, embryonic chimeras have been generated from
combinations of mouse and vole (Mystkowska, 1975), the
variant mouse species Mus musculus and Mus caroli (Rossant
and Frels, 1980), the variant cow species Bos taurus and Bos
indicus (Williams et al., 1990), and sheep and goat (Fehilly et
al., 1984). Not surprisingly, chimeras generated from the
more evolutionarily distant species were not viable, presum-
ably due to irreconcilable differences between developmental
programs—chimeras between mouse and vole or mouse and
rat, for instance, did not come to term and only rarely
developed to advanced stages in utero. On the other hand,
chimeras generated from mixing embryos of closely related
species (M. musculus and M. caroli, B. taurus, and B.
indicus, or sheep and goat) resulted in successful develop-
ment to adulthood. Considering these results, it seems
unlikely that chimeras generated from engraftment of
hESCs into mouse blastocysts would develop into viable
chimeric embryos. Our results show that the majority of
embryonic chimeras that implanted and retained hESC
derivatives were developmentally abnormal/delayed. Rarely,
however, hESCs persisted in morphologically normal embry-
os, demonstrating that hESC engraftment is not irreconcilable
with mouse embryogenesis. In fact, the differences between
mouse and human embryogenesis may account for these rare
morphologically normal embryos. In particular, the difference
in cell cycle between mouse and human ESCs may explain
the relative scarcity of hESC derivatives in our embryonic
chimeras at e8: considering our experimental design, in
which hESC contribution was intentionally minimized,
combined with the relatively slow pace of hESC proliferation
and/or human embryogenesis, it makes sense that hESC
derivatives should be underrepresented; and if human
contribution is minimized, the relatively brisk pace of
mouse development may allow the host cells to out-compete
the hESC derivatives, resulting in “pockets” of human cells
in a morphologically normal mouse embryo.
The observation that RUES1 localized to the ICM of host
blastocysts indicated that hESCs preferentially occupied a niche
that parallels that of their origin, the ICM. Yet, the emergence of
functional neurons from undifferentiated hESCs injected
directly into the lateral ventricles of e14 mouse brains (Muotri
et al., 2005) establishes that pluripotent human cells and their
derivatives can also respond appropriately to the inductive
signals of an evolutionarily distant niche. In the rare instance
where hESCs engrafted “ectopically” into regions of trophecto-
derm upon blastocyst formation (Figs. 6O–Q), most of the
hESC derivatives retained Oct-3/4 expression, but in a subset of
the engrafted cells, Oct-3/4 was completely lost, and a weak
Cdx2 signal was observed. While little can be concluded as to
the timing of differentiation in mouse vs. human cells from
these observations, they did provide some indication that human
cells were capable of taking on the molecular identity of the
niche into which they engrafted. Following from our work, it is
feasible that mouse/human chimeras could be generated in
which hESCs are engrafted into pre-implantation stage mouseembryos and distributed throughout the host anatomy through
gastrulation. This may allow for chimeras in which hESC
derivatives are “seeded” into an array of developmental niches
within a viable mouse, which would be of considerable value
for the modeling of human development and disease in live
animals.
While these experiments are in line with ethical guidelines
set forth by the National Academy of Sciences (Committee on
Guidelines for Human Embryonic Stem Cell Research and
National Research Council, 2005) (http://www.books.nap.edu/
catalog/11278.html), we purposefully restricted our analysis to
early developmental stages and minimized hESC engraftment in
order to affirm the feasibility of these assays. As such, the
current study is lacking in some respects. First, in order to
further explore the utility of embryonic chimeras as a vehicle for
examining the emergence and behavior of human cell types, we
must characterize the extent to which human cells can
contribute to a viable mouse–human chimera. Allowing
progression of chimeras to later developmental time points
would indicate whether hESC derivatives are capable of
integrating functionally into host anatomy. Second, in the rare
instances in which hESC derivatives persisted in morpholog-
ically normal chimeras, the observed GFP-positive cells could
have been a result of cell fusion rather than persistence of bona
fide human cells. Given the rarity of this phenotype and the
scarcity of presumed human cells, it is difficult to rule out the
possibility of cell fusion without increasing the scale of the
experiments and allowing further proliferation of hESC
derivatives within chimeras left to develop to later stages.
Regardless of whether human cells can accommodate the
spatiotemporal signaling environment and/or developmental
schedule of mouse embryogenesis in any or all instances, the
generation and culture of mouse/human chimeras in vitro may
at least allow for a study of the murine embryonic explant's
influence on hESC differentiation, yet engraftment of hESC
derivatives into live chimeric animal models would be a much
more valuable tool. Provided that hESCs can be reconciled with
mouse embryogenesis in vivo, engrafting hESCs into host
anatomy before gastrulation may provide an accessible platform
for studying the emergence of many human cell types; and with
the expansion of available hESCs to include genetically
diseased lines, mouse/human chimeras may allow us to
elucidate the bases of disease by examining the behavior of
such hESC lines in live animal models. In addition to their
contribution to the basic understanding of human embryology,
the advances reported here provide a foundation for future work
towards an understanding of human disease.
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